Search

everythinglearnresearchcommunity

for

Search:↓

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Heat treatment increases hair loss in certain mice.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Topical tacrolimus is effective and safe for treating alopecia areata.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Square-shaped hair loss can occur after treating a brain aneurysm due to localized radiation exposure.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.